2-Trifluoromethyl-5,6-dihydro-5,6-diacetyldibenzo[b,f][1,4,5]thiadiazepine

ID: ALA3265397

Chembl Id: CHEMBL3265397

PubChem CID: 46219780

Max Phase: Preclinical

Molecular Formula: C17H13F3N2O2S

Molecular Weight: 366.36

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(=O)n1c2ccccc2sc2cc(C(F)(F)F)ccc2n1C(C)=O

Standard InChI:  InChI=1S/C17H13F3N2O2S/c1-10(23)21-13-5-3-4-6-15(13)25-16-9-12(17(18,19)20)7-8-14(16)22(21)11(2)24/h3-9H,1-2H3

Standard InChI Key:  YPRAIJVRPSGJBP-UHFFFAOYSA-N

Associated Targets(Human)

SH-SY5Y (11521 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ACHE Acetylcholinesterase (1035 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Cholinesterase (8742 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 366.36Molecular Weight (Monoisotopic): 366.0650AlogP: 5.12#Rotatable Bonds:
Polar Surface Area: 44.00Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 3.35CX LogD: 3.35
Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.55Np Likeness Score: -1.17

References

1. González-Muñoz GC, Arce MP, Pérez C, Romero A, Villarroya M, López MG, Conde S, Rodríguez-Franco MI..  (2014)  Dibenzo[1,4,5]thiadiazepine: a hardly-known heterocyclic system with neuroprotective properties of potential usefulness in the treatment of neurodegenerative diseases.,  81  [PMID:24858540] [10.1016/j.ejmech.2014.04.075]

Source